Dr. Klee is a research consultant with an appointment in Quantitative Health Sciences (QHS) and joint appointments in Clinical Genomics and Laboratory Medicine and Pathology. He has played a key role in the Mayo Clinic Center for Individualized Medicine (CIM) developing the Omics Data Platform (ODP), which is essential to comprehensive clinical genomic sequencing in the cancer clinical practice.